Kelly de Ligt, PhD, discusses subgroups of symptom burden seen in breast cancer survivors.
Kelly de Ligt, PhD
Advertisement
Articles by Kelly de Ligt, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
2
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
3
MAIC Shows OS Benefit With Mogamulizumab vs Vorinostat in Cutaneous T-Cell Lymphoma Subtypes
4
Analysis Identifies Potential Response, Resistance Biomarkers to Mogamulizumab in R/R Mycosis Fungoides/Sézary Syndrome
5